FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of the partial clinical hold on long-term studies Separately, FDA recently issued labeling ...

Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. With the trial linking tradipitant to reduced nausea and vomiting in Wegovy patients, the biotech is gearing ...

The Khmer Boxing Federation (KBF) has appointed Nin Vanda as acting secretary-general, replacing Sien Sopheak, who submitted his resignation on September 19. The appointment was made at AEON Mall 3 on ...

Shares of Vanda Pharmaceuticals fell after the company reported a third-quarter loss that wider than a year ago and dropped the high end of its full-year revenue view. The stock was 18% lower, at ...

WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $22.6 million in its third quarter. The Washington-based company said it had a loss of 38 cents ...

BELMONT PARK, N.Y., Oct. 8, 2025 /CNW/ -- The New York Islanders today announced a multi-year agreement with Vanda Pharmaceuticals, a global biopharmaceutical company, naming them the team's exclusive ...

Vanda Pharmaceuticals, a company that develops medicines for conditions with limited to no treatment options, has signed a multi-year partnership with the New York Islanders to become their jersey ...

Add articles to your saved list and come back to them any time. Sixty years ago this week, Harry Vanda was in a world gone mad. As the Easybeats promoted their 1965 debut album Easy and its ...

Vanda Pharmaceuticals has agreed to a plan in which the Food and Drug Administration will conduct more reviews of two of its drugs to resolve disputes between the company and the agency. Under the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The ruling sets the stage for a ...

WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its ...